{"product_id":"biolegend-628501","title":"Biolegend, 628501, Purified anti-Cytokeratin 19 Antibody, 25μg","description":"\u003cp\u003eCytokeratin 19, also known as keratin 19, is a type I intermediate filament protein with a molecular weight of approximately 40-44 kD. Cytokeratin 19 is a heterotetramer composed of two type I and two type II keratin subunits. Unlike other cytokeratins, cytokeratin 19 lacks a C-terminal non-helical extension. This cytokeratin is widely expressed in the periderm (transient superficial layer enveloping developing epidermis), muscle, intestine, bile duct, esophagus, stomach, and thymus. Cytokeratin 19 can be upregulated by vitamin A and is thought to play a critical role in embryogenesis. Cytokeratin 19 intereacts with the pinin protein and has been shown to be modified by phosphorylation (Ser10, Ser35).\u003cbr\u003e\n25μg\u003cbr\u003e\nVerified Reactivity: Human\u003cbr\u003e\nAntibody Type: Monoclonal\u003cbr\u003e\nHost Species: Mouse\u003cbr\u003e\nImmunogen: Human mammary carcinoma cell line MCF-7\u003cbr\u003e\nFormulation: This antibody is provided in phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide at 0.5 mg\/ml.\u003cbr\u003e\nPreparation: The antibody was purified by affinity chromatography.\u003cbr\u003e\nConcentration: 0.5 mg\/ml\u003cbr\u003e\nStorage \u0026amp; Handling: The antibody solution should be stored undiluted between 2°C and 8°C.\u003cbr\u003e\nApplication: WB - Quality testedICC - VerifiedIP, IHC-P, ELISA - Reported in the literature, not verified in house\u003cbr\u003e\nRecommended Usage: Each lot of this antibody is quality control tested by Western blotting. Western blotting, suggested working dilution(s): Use 5 µg antibody per 5 ml antibody dilution buffer for each mini-gel. It is recommended that the reagent be titrated for optimal performance for each application.\u003cbr\u003e\nApplication Notes: Additional reported applications (for the relevant formats) include: immunoprecipitation, immunohistochemistry of paraffin-embedded sections, immunocytochemistry, and ELISA.\u003cbr\u003e\nApplication References(PubMed link indicates BioLegend citation): Karsten U, et al. 1985. Eur. J. Cancer Clin. Oncol. 21:733. Nishikata T,et al. Anticancer Res. 33:2867. PubMed\u003cbr\u003e\nProduct Citations: Haensel D, et al. 2022. Nat Commun. 13:7520. PubMed McMahon NP, et al. 2023. Cancers (Basel). 15: . PubMed Burlingame EA, et al. 2021. Cell Rep Methods. 1:. PubMed Risom T, et al. 2020. J Clin Invest. 130:231. PubMed Shalabi SF, et al. 2021. Nat Aging. 1:838. PubMed NISHIKATA T, et al. 2013. Anticancer Res. 33:2867. PubMed Rohena C, et al. 2013. Biochem Pharmacol. 85:1104. PubMed Li Z, et al. 2020. J Clin Lab Anal. 34:e23155. PubMed Johnson BE, et al. 2022. Cell Rep Med. 3:100525. PubMed\u003cbr\u003e\nRRID: AB_439773 (BioLegend Cat. No. 628502)\u003cbr\u003e\nStructure: Type I intermediate filament protein, contains three coiled-coil domains, lacks C-terminal non-helical extension found in other keratins, approximately 40-44 kD. Cytokeratin 19 is a heterotetramer composed of two type I and two type II keratin subunits.\u003cbr\u003e\nDistribution: Expressed in the periderm (transient superficial layer enveloping developing epidermis), also expressed in muscle, intestine, bile duct, esophagus, stomach, and thymus. Upregulated by vitamin A.\u003cbr\u003e\nFunction: Intermediate filament protein involved with the cytoskeleton. May play a critical role in embryogenesis\u003cbr\u003e\nInteraction: Interacts with pinin\u003cbr\u003e\nModification: Phosphorylation (Ser10, Ser35)\u003cbr\u003e\nBiology Area: Cell Biology, Cell Motility\/Cytoskeleton\/Structure, Neuroscience, Neuroscience Cell Markers\u003cbr\u003e\nMolecular Family: Intermediate Filaments\u003cbr\u003e\nAntigen References: 1. Bader BL, et al. 1986. EMBO J. 5:1865. 2. Eckert RL. 1988. Proc. Natl. Acad. Sci. 85:1114. 3. Stasiak PC and Lane EB. 1987 Nucleic Acids Res. 15:10058.\u003cbr\u003e\nGene ID: 3880\u003cbr\u003e\nUniProt: View information about Cytokeratin 19 on UniProt.org\u003cbr\u003e\nClone: A53-B\/A2\u003cbr\u003e\nRegulatory Status: RUO\u003cbr\u003e\nOther Names: Keratin 19, Keratin 19 type 1 cytoskeletal\u003cbr\u003e\nIsotype: Mouse IgG2a, κ\u003c\/p\u003e","brand":"Biolegend","offers":[{"title":"Default Title","offer_id":46866450776233,"sku":"628501","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/es\/products\/biolegend-628501","provider":"Iright","version":"1.0","type":"link"}